EE438 Budget Impact Analysis of Lanadelumab Versus C1 Inhibitor for Hereditary Angioedema Long Term Prophylaxis: A Brazilian Private Sector Perspective
Abstract
Authors
Tatiane Ribeiro Lucas Azevedo Juliana Guedes Bruno B. Rosa Daniela Morais